Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BioMarin (BMRN) upgraded to Conviction Buy at Goldman by analyst Salveen Richter, who said "multiple pipeline catalysts" will drive value in 2016. 2. Cardinal Health (CAH) upgraded to Conviction Buy at Goldman with analyst Robert Jones believing industry drivers are normalizing, expectations have been reset, and execution from recent deals should drive upside. 3. Grand Canyon (LOPE) upgraded to Outperform at Credit Suisse by analyst Trace Urdan, who said CapEx spending should come down over the next several years, resulting in accelerating free cash flow growth. 4. General Growth (GGP) upgraded to Buy at Evercore ISI with analyst Steve Sakwa saying that the company's decision to lower leverage and its recent leasing success should help support shares. 5. Simon Property (SPG) upgraded to Buy at Evercore ISI by analyst Steve Sakwa, who said the company's strong balance sheet and development pipeline support external growth. He adds that the company is expected to benefit from the GICs change that will occur later this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.